# COXANTO
> **NDA217927** · New Drug Application · Sponsor: SOLUBIOMIX · Approved 2023-10-20
## Drug
- **FDA Application Number:** NDA217927
- **Application type:** New Drug Application
- **Brand name:** COXANTO
- **Generic name:** OXAPROZIN
- **Active ingredients:** OXAPROZIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SOLUBIOMIX
- **Manufacturer:** SOLA Pharmaceuticals, LLC
- **First approval:** 2023-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217927)
---
*MORVS · CC0 1.0*